Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets

Journal of Immunological Methods

Volumn 369, Issue 1-2, 2011, Pages 59-68

  Schuler, Patrick J ^a,b   Harasymczuk, Malgorzata ^a   Schilling, Bastian ^a   Lang, Stephan ^b   Whiteside, Theresa L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Adenosine; Cancer; CD39; CD73; FOXP3; Treg

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE TRIPHOSPHATE; ALPHA4 INTEGRIN; AVIDIN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD39 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SELECTION; FEMALE; FLOW CYTOMETRY; GENETIC PURITY; HUMAN; HYDROLYSIS; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; APYRASE; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; HUMANS; IMMUNOMAGNETIC SEPARATION; MAGNETICS; PHENOTYPE; SURFACE PROPERTIES;

EID: 79958781930     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.04.004     Document Type: Article

References (28)

1. Baecher-Allan C., Hafler D.A. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 2006, 212:203.
2. Baecher-Allan C.M., Hafler D.A. The Purification and Functional Analysis of Human CD4+CD25high Regulatory T Cells. Current Protocols in Immunology 2006, 72:7.4B.1-7.4B.12.
3. Borsellino G., Kleinewietfeld M., Di Mitri D., Sternjak A., Diamantini A., Giometto R., Hopner S., Centonze D., Bernardi G., Dell'Acqua M.L., Rossini P.M., Battistini L., Rotzschke O., Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007, 110:1225.
4. Chiacchio T., Casetti R., Butera O., Vanini V., Carrara S., Girardi E., Di Mitri D., Battistini L., Martini F., Borsellino G., Goletti D. Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis. Clin. Exp. Immunol. 2009, 156:463.
5. Deaglio S., Dwyer K.M., Gao W., Friedman D., Usheva A., Erat A., Chen J.F., Enjyoji K., Linden J., Oukka M., Kuchroo V.K., Strom T.B., Robson S.C. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007, 204:1257.
6. Dwyer K.M., Deaglio S., Gao W., Friedman D., Strom T.B., Robson S.C. CD39 and control of cellular immune responses. Purinergic. Signal. 2007, 3:171.
7. Dwyer K.M., Hanidziar D., Putheti P., Hill P.A., Pommey S., McRae J.L., Winterhalter A., Doherty G., Deaglio S., Koulmanda M., Gao W., Robson S.C., Strom T.B. Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am. J. Transplant. 2010, 10:2410.
8. Ebert L.M., Tan B.S., Browning J., Svobodova S., Russell S.E., Kirkpatrick N., Gedye C., Moss D., Ng S.P., MacGregor D., Davis I.D., Cebon J., Chen W. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res. 2008, 68:3001.
9. Fletcher J.M., Lonergan R., Costelloe L., Kinsella K., Moran B., O'Farrelly C., Tubridy N., Mills K.H. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J. Immunol. 2009, 183:7602.
10. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., Ocheltree E.L., Greenberg P.D., Ochs H.D., Rudensky A.Y. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 2006, 103:6659.
11. Hilchey S.P., Kobie J.J., Cochran M.R., Secor-Socha S., Wang J.C., Hyrien O., Burack W.R., Mosmann T.R., Quataert S.A., Bernstein S.H. Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness. J. Immunol. 2009, 183:6157.
12. Kleinewietfeld M., Starke M., Di Mitri D., Borsellino G., Battistini L., Rotzschke O., Falk K. CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. Blood 2009, 113:827.
13. Kryczek I., Liu R., Wang G., Wu K., Shu X., Szeliga W., Vatan L., Finlayson E., Huang E., Simeone D., Redman B., Welling T.H., Chang A., Zou W. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res. 2009, 69:3995.
14. Law J.P., Hirschkorn D.F., Owen R.E., Biswas H.H., Norris P.J., Lanteri M.C. The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells. Cytometry A 2009, 75:1040.
15. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., Fazekas de St G.B., Clayberger C., Soper D.M., Ziegler S.F., Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006, 203:1701.
16. Mandapathil M., Lang S., Gorelik E., Whiteside T.L. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J. Immunol. Methods 2009, 346:55.
17. Mittag D., Scholzen A., Varese N., Baxter L., Paukovics G., Harrison L.C., Rolland J.M., O'Hehir R.E. The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells. J. Immunol. 2010, 184:4708.
18. Miyara M., Wing K., Sakaguchi S. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J. Allergy Clin. Immunol. 2009, 123:749.
19. Moncrieffe H., Nistala K., Kamhieh Y., Evans J., Eddaoudi A., Eaton S., Wedderburn L.R. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J. Immunol. 2010, 185:134.
20. Peters J.H., Preijers F.W., Woestenenk R., Hilbrands L.B., Koenen H.J., Joosten I. Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation. PLoS One 2008, 3:e3161.
21. Ring S., Oliver S.J., Cronstein B.N., Enk A.H., Mahnke K. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism. J. Allergy Clin. Immunol. 2009, 123:1287.
22. Robson S.C., Wu Y., Sun X., Knosalla C., Dwyer K., Enjyoji K. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin. Thromb. Hemost. 2005, 31:217.
23. Sakaguchi S., Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T. Regulatory T cells: how do they suppress immune responses?. Int. Immunol. 2009, 21:1105.
24. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10:490.
25. Sitkovsky M.V., Kjaergaard J., Lukashev D., Ohta A. Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin. Cancer Res. 2008, 14:5947.
26. Strauss L., Bergmann C., Gooding W., Johnson J.T., Whiteside T.L. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2007, 13:6301.
27. Sun X., Wu Y., Gao W., Enjyoji K., Csizmadia E., Muller C.E., Murakami T., Robson S.C. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 2010, 139(3):1030-1040.
28. Zhou Q., Yan J., Putheti P., Wu Y., Sun X., Toxavidis V., Tigges J., Kassam N., Enjyoji K., Robson S.C., Strom T.B., Gao W. Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations. Am. J. Transplant. 2009, 9:2303.